The relationship between HMGB1 and pyroptosis in cancer therapy presents a complex paradox, wherein this DAMP can function as either an antagonist or protagonist of treatment efficacy, largely determined by contextual factors within the tumor microenvironment. The gene discussed is HMGB1; the disease is cancer.